Siew Pheng Lim

Siew Pheng Lim, PhD, is currently serving as the Chief Scientific Officer and Preclinical Project Manager at Singzyme since October 2023. With extensive experience in editorial roles, Siew Pheng Lim holds positions on the Editorial Board for several journals, including Antiviral Research with Elsevier Inc. since November 2011, and serves as Associate Editor for Antivirals and Vaccines at Frontiers in Virology since March 2021. Additional editorial contributions include roles at Frontiers in Microbiology, Pathogens, and Heliyon, among others. Siew Pheng Lim previously held the position of Director, Discovery Biology I at the Experimental Drug Development Centre, A*STAR, and was a Research Director at Denka Life Innovation Research Pte Ltd. An academic background includes an Adjunct Associate Professor role at Duke-NUS Medical School and significant research experience at Novartis Institute for Tropical Diseases. Educational qualifications include a PhD in Immunology from the Institute of Molecular and Cell Biology, A*STAR, a Bachelor of Science in Microbiology from the National University of Singapore, and a Graduate Diploma in Organizational Psychology from Aventis Graduate School.